[3-(3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]amine

Catalog No. :
ACPXKS548
CAS No. :
1204296-89-8
Molecular Formula :
C16H12N6
Molecular Weight :
288.31

IUPAC Name:3-(3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)aniline

[3-(3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$228.00Login to see priceInquiryInquiry
100mg98%$332.00Login to see priceInquiryInquiry
250mg98%$469.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[3-(3-pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]amine
IUPAC Name3-(3-(pyridin-3-yl)-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)aniline
Molecular FormulaC16H12N6
Molecular Weight288.31
SMILESNC1=CC=CC(C2=NN3C(C=C2)=NN=C3C4=CC=CN=C4)=C1
InChI KeyAXPOYJCBQWSQTK-UHFFFAOYSA-N
Synonym[3-(3-Pyridin-3-yl[1,2,4]triazolo[4,3-b]pyridazin-6-yl)phenyl]amine;3-(3-pyridin-3-yl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)aniline;Benzenamine, 3-[3-(3-pyridinyl)-1,2,4-triazolo[4,3-b]pyridazin-6-yl]-
CAS No.1204296-89-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPXKS548 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPXKS548 route product structure diagram
    ACPXKS5481204296-89-8
Inquiry

2. ACPXKS548 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKDRS250 route compound structure diagram
    ACKDRS25030418-59-8 In Stock
  4. Then
  5. ACPXKS548 route product structure diagram
    ACPXKS5481204296-89-8
Inquiry

Comments (0)